Webb Kevin L, Reilly Charles E, Hinkle Mickayla L, Shinya Yuki, Van Gompel Jamie J, Meyer Fredric B
Mayo Clinic Alix School of Medicine, Rochester, MN, USA.
Department of Neurologic Surgery, Mayo Clinic, Rochester, MN, USA.
Neurosurg Rev. 2025 Sep 2;48(1):630. doi: 10.1007/s10143-025-03784-8.
The transsphenoidal approach to sellar lesions is a mainstay technique in modern neurosurgical treatment of pituitary adenomas. One prominent complication following transsphenoidal surgery is the development of postoperative hyponatremia, frequently necessitating additional medical management and hospital readmission. However, the precise incidence and risk factors of postoperative hyponatremia remain unclear in the current literature. We conducted a systematic meta-analysis of 104 studies (31,676 patients) to clarify the incidence of postoperative hyponatremia and associated hospital readmission, as well as to summarize conflicting findings regarding significant risk factors of postoperative hyponatremia. The overall incidence of postoperative hyponatremia following transsphenoidal surgery was 13.3% [95% Confidence Interval (CI): 11.8-14.7%; 96 studies]. The rate of hospital readmission due to postoperative hyponatremia was 3.3% [95% CI: 2.7-3.9%; 33 studies]. Factors such as infundibular stalk deviation angle, plasma copeptin level, and Knosp grades served as more reliable predictors of postoperative hyponatremia. In contrast, conventional demographic and surgical parameters such as patient age, body mass index, sex, and extent of resection were not consistently identified as significant predictive factors. Secondary analyses revealed that prophylactic fluid restriction significantly reduced the incidence of postoperative hyponatremia from ~ 13.1% to ~ 4.0% (Odds Ratio 3.39 [95% CI; 2.18-5.26, Z = 5.545, P < 0.001]. This meta-analysis establishes definitive 'benchmarks' for anticipated complications after transsphenoidal surgery while highlighting important factors such as prophylactic fluid restriction protocols as a key source of inter-study variability. In addition, this study summarizes the congruence of the predictive factors thought to be influential in leading to postoperative hyponatremia, highlighting key areas of (dis)agreement.
经蝶窦入路治疗鞍区病变是现代神经外科治疗垂体腺瘤的主要技术。经蝶窦手术后一个突出的并发症是术后低钠血症的发生,这常常需要额外的医疗处理和再次住院。然而,目前文献中术后低钠血症的确切发生率和危险因素仍不明确。我们对104项研究(31676例患者)进行了系统的荟萃分析,以明确术后低钠血症的发生率及相关的再次住院情况,并总结关于术后低钠血症重要危险因素的相互矛盾的研究结果。经蝶窦手术后术后低钠血症的总体发生率为13.3%[95%置信区间(CI):11.8 - 14.7%;96项研究]。因术后低钠血症再次住院的发生率为3.3%[95%CI:2.7 - 3.9%;33项研究]。漏斗柄偏斜角度、血浆 copeptin 水平和 Knosp 分级等因素是术后低钠血症更可靠的预测指标。相比之下,传统的人口统计学和手术参数,如患者年龄、体重指数、性别和切除范围,并未始终被确定为显著的预测因素。二次分析显示,预防性液体限制显著降低了术后低钠血症的发生率,从约13.1%降至约4.0%(优势比3.39[95%CI;2.18 - 5.26,Z = 5.545,P < 0.001])。这项荟萃分析为经蝶窦手术后预期并发症确立了明确的“基准”,同时强调了预防性液体限制方案等重要因素是研究间差异的关键来源。此外,本研究总结了被认为对导致术后低钠血症有影响的预测因素的一致性,突出了(不)一致的关键领域。